You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PTCY

Showing 26 - 50 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • ATIR101
  • +3 more
  • Duarte, California
  • +41 more
Apr 28, 2022

Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute

Not yet recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Hematopoietic Stem Cell Transplantation Trial in China (ATG, CTX, Mycophenolate Mofetil)

Unknown status
  • Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
  • +6 more
Oct 24, 2019

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)

Recruiting
  • Graft-versus-host Disease
  • New York, New York
    NYU Langone Health
Mar 24, 2022

GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

Recruiting
  • Graft Versus Host Disease
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
May 4, 2022

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • (no location specified)
Apr 10, 2023

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival Trial in Canada, United States (drug,

Completed
Has Results
  • Myeloablative Conditioning
  • +3 more
  • Aurora, Colorado
  • +8 more
Nov 23, 2021

Graft-versus-host-disease, Prophylaxis Trial in Shanghai (ATG)

Unknown status
  • Graft-versus-host-disease
  • Prophylaxis
  • Shanghai, Shanghai, China
    Shanghai First People's HOSPITAL
Apr 13, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • EAGD T-cell infusion (Phase I)
  • EAGD T-cell infusion (Expansion)
  • Westwood, Kansas
    University of Kansas Cancer Center
Mar 15, 2022

Leukemia, Chronic Myeloid, MDS, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Trial in Saint-Petersburg (Unrelated

Terminated
  • Leukemia, Chronic Myeloid
  • +2 more
  • Unrelated allogeneic stem cell transplantation
  • +6 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Apr 3, 2019

Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

Recruiting
  • Primary T-cell Immunodeficiency Disorders
  • +4 more
  • Immunosuppression Only Conditioning -Closed with amendment L
  • +4 more
  • Bethesda, Maryland
  • +1 more
Jul 26, 2022

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

Recruiting
  • Lymphoproliferative Disorders
  • +4 more
  • Immunosuppression Only Conditioning
  • +3 more
  • Bethesda, Maryland
  • +1 more
Jan 25, 2023

Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Blood and Marrow Transplant
  • Minneapolis, Minnesota
    Masonic Caner Center at University of Minnesota
May 23, 2022

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Haploidentical hematopoietic cell transplantation (haploHCT)
  • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
  • (no location specified)
Jul 13, 2022